Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

OxiGene (OXGN)

Add to Watchlists
Create an Alert
3.25 +0.14  +4.50% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
OXGN Price Chart
View All Events

OXGN Events

Date Type Description
Mar 18 Misc OxiGene, Inc. Q4 2013 Earnings Conference Call
Mar 18 Earnings OxiGene, Inc. Q4 2013 Earnings Results.
Nov 12 Misc Oxigene Announces Third Quarter 2013 Earnings Conference Call and Webcast
Nov 12 Earnings Third Quarter 2013 Financial Results.
Aug 06 Misc Oxigene Announces Second Quarter 2013 Earnings Conference Call and Webcast
Aug 06 Earnings Second Quarter 2013 Financial Results.
Jul 16 Misc AGM Event for Oxigene, Inc.
May 06 Misc Oxigene Announces First Quarter 2013 Earnings Conference Call and Webcast
May 06 Earnings First Quarter 2013 Financial Results.
View All Performance Charts

OXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is down 7.14% over the last year vs S&P 500 Total Return up 22.59%, La Jolla Pharmaceutical up 133.3%, and Aastrom Biosciences down 69.07%.

Get Quote for

Portfolio Strategies Featuring OXGN

Did OxiGene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OXGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

OxiGene, Inc., is a biopharmaceutical company. It is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer.

Recent Quotes

Symbol Price Chg Chg % Market Cap
OXGN 3.25 +0.14 +4.50% 18.15M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.